The Trump administration has pushed corporations to open more facilities in the U.S., emphasizing its “America first” policies that seek to discourage imports and increase manufacturing ...

At the ongoing News18 Showsha Reel Awards 2025 currently underway in Mumbai, actress Jyothika has been honoured with the Best Supporting Actress (Popular Choice) Award for her exceptional performance ...

Investing.com - The U.S. dollar edged higher Thursday, bouncing from near five-month lows in the wake of the Federal Reserve’s latest policy-setting meeting, while sterling edged lower after ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

LGM Pharma, announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its Phase I CDMO growth strategy. The expansion will increase capacity for ...

The real (price adjusted) stock of orders in manufacturing was unchanged (0.0%) in January 2025 compared with December 2024 after seasonal and calendar adjustment, according to provisional figures of ...

Federal regulations like the Current Good Manufacturing Practices (cGAMPs) enforced by the United States Food and Drug Administration (FDA), European Medicines Agency (EMA), and other ...

The Vietnam Briefing Magazine was first published in 2009, and is contributed to by investment professionals based in Vietnam. The manufacturing sector is the cornerstone of Vietnam’s economic growth ...

Advances in manufacturing (faster, cheaper, smarter) don’t always result from one big technological breakthrough: Much of the work of innovation involves building on what people have ...

according to more than a half dozen pharma industry sources with direct knowledge of the discussions. Sign up here. Some are signalling a willingness to expand manufacturing in the United States ...

Pfizer PFE0.80%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

I don't think big mergers are likely in the imminent future. How do you view the overall pharma business scenario? The branded generics business grows slower than the commodity business, but it lasts ...